A committee of independent medical experts convenes Friday to review Johnson & Johnson ’s Covid-19 single-dose vaccine, the final step before U.S. health regulators decide whether to authorize use of a third shot.
The panel, which includes 22 medical specialists in fields like internal medicine, pediatrics, vaccines and epidemiology, regularly advises the U.S. Food and Drug Administration about experimental vaccines. It voted to recommend shots from Pfizer Inc. and Moderna Inc.If the panel votes to endorse the J&J shot, the agency is expected to permit the product’s wide use as soon as Saturday.
During the all-day public meeting, representatives from the FDA and J&J will discuss the safety and effectiveness of the company’s vaccine in a 44,000-plus subject study, according to an agenda. The vaccine was 66% effective at protecting people from moderate to severe Covid-19, an FDA review found, and even more effective at preventing severe disease alone.
Hi, i'm a student in high school, Turkey. The number of cases is very high and we are subjected to face to face exams. We need your help please hear our voices. We don't want to die! WHOSaveTurkishStudents
yaiptalyaistifa TurkishStudentsLivesMatters Hi, I'm a high school student in Turkey. Unfortunately, although the number of cases in our country is high, our exams will take place face to face 2 million students cannot access distance education in our country. Please support us
Do you think this is what people really need right now?
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.